SCHEMBL9732893

SCHEMBL9732893

C=CCC(CCCC#N)CCC(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.39
ABCC4 O15439 1/20 0.39
CYP2D6 P10635 3/20 0.38
NFKB1 P19838 3/20 0.38
CYP2C19 P33261 2/20 0.38
TSHR P16473 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
BLM P54132 1/20 0.38
SLC6A3 Q01959 1/20 0.38
GSTK1 Q9Y2Q3 2/20 0.37
ALDH1A1 P00352 1/20 0.32
LMNA P02545 3/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
HSD17B10 Q99714 1/20 0.32
PMP22 Q01453 1/20 0.31
SLC1A2 P43004 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11580020 0.84 GSTK1 (0.52) MAPTABCC4CYP2D6NFKB1CYP2C19
SCHEMBL9709901 0.80 SLC1A2 (0.38) CYP2C19MEN1KMT2AALDH1A1SLC1A2
SCHEMBL10824781 0.80 TSHR (0.50) MAPTABCC4CYP2D6NFKB1CYP2C19
SCHEMBL9709877 0.79 KMT2A (0.40) TSHRMEN1KMT2AALDH1A1CYP1A2
SCHEMBL9709564 0.77 ALDH1A1 (0.38) TSHRALDH1A1LMNA
SCHEMBL9709906 0.76 TSHR (0.34) TSHR
SCHEMBL9733201 0.75 CYP1A2 (0.40) MAPTCYP2D6NFKB1CYP2C19TSHR
SCHEMBL11147230 0.74 TSHR (0.45) MAPTABCC4CYP2D6NFKB1CYP2C19
SCHEMBL5677958 0.74 GRIK1 (0.46) MAPTABCC4CYP2C19MEN1KMT2A
SCHEMBL2359759 0.73 TSHR (0.44) MAPTABCC4CYP2D6NFKB1CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5153214-A Treating cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1992-10-06 US disclosed
US-5025025-A Cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1991-06-18 US disclosed
EP-0405391-A1 Certain (arylsulfonamido- and pyridyl- or imidazolyl-)-substituted carboxylic acids and derivatives thereof CIBA-GEIGY AG (CH) 1991-01-02 EP disclosed